CHEBI:61397 - neratinib

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name neratinib
ChEBI ID CHEBI:61397
Definition A quinoline compound having a cyano group at the 3-position, a 3-chloro-4-(2-pyridylmethoxy)anilino group at the 4-position, a 4-dimethylamino-trans-but-2-enoylamido group at the 6-position, and an ethoxy group at the 7-position.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C30H29ClN6O3
Net Charge 0
Average Mass 557.050
Monoisotopic Mass 556.19897
InChI InChI=1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+
InChIKey JWNPDZNEKVCWMY-VQHVLOKHSA-N
SMILES C1(=C(C=C2C(=C1)C(=C(C=N2)C#N)NC3=CC=C(C(=C3)Cl)OCC4=NC=CC=C4)OCC)NC(/C=C/CN(C)C)=O
Roles Classification
Biological Role(s): tyrosine kinase inhibitor
Any protein kinase inhibitor that interferes with the action of tyrosine kinase.
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing neratinib (CHEBI:61397) has role antineoplastic agent (CHEBI:35610)
neratinib (CHEBI:61397) has role tyrosine kinase inhibitor (CHEBI:38637)
neratinib (CHEBI:61397) is a nitrile (CHEBI:18379)
neratinib (CHEBI:61397) is a quinolines (CHEBI:26513)
IUPAC Name
(2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
INN Source
neratinib KEGG DRUG
Synonyms Sources
HKI 272 ChemIDplus
HKI-272 ChemIDplus
N-(4-(3-Chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide ChemIDplus
Manual Xref Database
D08950 KEGG DRUG
View more database links
Registry Numbers Types Sources
698387-09-6 CAS Registry Number ChemIDplus
9971763 Reaxys Registry Number Reaxys
Citation Waiting for Citations Type Source
15715478 PubMed citation Europe PMC
Last Modified
28 November 2019